Hemoglobinuria

In medicine, hemoglobinuria is a condition in which the oxygen transport protein hemoglobin is found in abnormally high concentrations in the urine. The condition is often associated with hemolytic anemia, in which red blood cells are destroyed, thereby increasing levels of free plasma hemoglobin. The excess hemoglobin is filtered by the kidneys, which release it into the urine, giving urine a red colour. (From the Wikpedia article Hemoglobinuria.)

Download PDF containing detailed information.

Recent Publications on Hemoglobinuria:
Whole or parts--the fate of hemoperitoneum. The complement system is composed of more than 30 serum and membrane-bound...	6th November, 2009	Department of Pediatrics, The Hospital for Sick Children, Toronto,	Surgery. 2009 Nov;146(5):947-9. Epub 2009 May 8. DOI Direct Link
Travels and travails of autoimmunity: A historical journey from discovery to rediscovery. Consideration on autoimmunity began, as did immunology itself, around year...	4th November, 2009	Department of Biochemistry & Molecular Biology, Monash University,	Autoimmun Rev. 2009 Oct 31. DOI Direct Link
Clinical significance of complement deficiencies. The complement system is composed of more than 30 serum and membrane-bound...	30th October, 2009	Division of Rheumatology, Allergy and Clinical Immunology, University of	Ann N Y Acad Sci. 2009 Sep;1173:108-23. DOI Direct Link
Autoantibody formation after alloimmunization inducing bystander immune hemolysis. The development of RBC autoantibodies resulting from or associated with...	28th October, 2009	Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Sao	Immunohematology. 2009;25(1):9-12.
Severe atypical HUS caused by CFH S1191L-case presentation and review of treatment options. Atypical hemolytic uremic syndrome (aHUS) has been associated with...	27th October, 2009	Division of Nephrology, The Hospital for Sick Children, 555 University	Pediatr Nephrol. 2009 Oct 24. DOI Direct Link
→View more research publications.

Press Releases About Hemoglobinuria:
Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications	26th October, 2009	Reportlinker	NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Immunotherapies and Vaccines for Nontraditional
Teva's 'Patient First' Initiative Highlights Struggle Against High Health Care Costs, Reminds Lawmakers of Reform Goals	20th August, 2009	Teva Pharmaceuticals USA	Real Americans Share Experiences, Common Need for Patient-Centric Reform WASHINGTON, Aug. 20 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH	8th December, 2008	Alexion Pharmaceuticals, Inc.	CHESHIRE, Conn., Dec. 8 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported positive results from AEGIS, an open-label registration study examining Soliris(R)
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting	10th November, 2008	Alexion Pharmaceuticals, Inc.	Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals
InCode BioPharmaceutics, Inc. Announces Key Safety Data for rC3-1: A New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)	28th July, 2008	InCode BioParmaceutics, Inc.	SAN FRANCISCO, July 28 /PRNewswire/ -- InCode BioPharmaceutics, Inc. today announced favorable results of its preclinical primate toxicity study demonstrating no adverse events and reduction of

BioNews Results for Hemoglobinuria:
Alexion Pharmaceuticals to Present Soliris Data at Annual ASH Meeting	TradingMarkets:  Nov 13 2009 5:28AM Matching: hemoglobinuria
Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At Th	Medical News Today:  Nov 12 2009 6:19AM Matching: hemoglobinuria
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the A	Pharma Live:  Nov 12 2009 12:03AM Matching: hemoglobinuria
News and FDA Updates for Alexion (Nasdaq:ALXN), Biogen (NASDAQ:BIIB), Elan (NYSE:ELN)	Los Angeles Chronicle:  Nov 12 2009 9:58AM Matching: hemoglobinuria
News and FDA Updates for Alexion (Nasdaq:ALXN), Biogen (NASDAQ:BIIB), Elan (NYSE:ELN)	American Chronicle:  Nov 12 2009 7:53AM Matching: hemoglobinuria
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Hemoglobinuria Clinical Trials:
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

Hemoglobinuria Patents:
US Patent No.	Title
7488590	Modified peptides as therapeutic agents
7528236	Humanized anti-beta7 antagonists and uses therefor
7531310	Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11
7538211	Aptamer therapeutics useful in the treatment of complement-related disorders
7541184	Activation and expansion of cells
→View more patents.

Companies working in the area of Hemoglobinuria from Bioportfolio's Biocorporate database :
Company Name
Alexion Pharmaceuticals Incorporated Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra... www.alexionpharm.com/        View full profile
BioCytex Since the foundation of Biocytex in the early 90's in the close proximity of the University and Hospital Complex of La Timone / La Conception in Marseille (France), the need of standardization in flow... www.biocytex.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Hemoglobinuria scientists - we have details of around 391 individuals working on Hemoglobinuria .